Encompass Health Corporation Common Stock earnings per share and revenue
On Feb 05, 2026, EHC reported earnings of 1.46 USD per share (EPS) for Q4 25, beating the estimate of 1.31 USD, resulting in a 11.35% surprise. Revenue reached 1.54 billion, compared to an expected 1.56 billion, with a -0.79% difference. The market reacted with a +5.86% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 1.51 USD, with revenue projected to reach 1.60 billion USD, implying an increase of 3.42% EPS, and increase of 3.60% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.39
Surprise
+6.37%
FAQ
What were Encompass Health Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Encompass Health Corporation Common Stock reported EPS of $1.46, beating estimates by 11.35%, and revenue of $1.54B, -0.79% below expectations.
How did the market react to Encompass Health Corporation Common Stock's Q4 2025 earnings?
The stock price moved up 5.86%, changed from $99.56 before the earnings release to $105.39 the day after.
When is Encompass Health Corporation Common Stock expected to report next?
The next earning report is scheduled for Apr 22, 2026.
What are the forecasts for Encompass Health Corporation Common Stock's next earnings report?
Based on 11
analysts, Encompass Health Corporation Common Stock is expected to report EPS of $1.51 and revenue of $1.60B for Q1 2026.